跳至主要内容
临床试验/NCT04761211
NCT04761211已完成不适用

Effect and Safety of Smart Bra of Peking Union Medical College & Hospital

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 2,141 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,141
试验地点
1
主要终点
Sensitivity

研究概览

简要总结

This is a multicenter, prospective clinical study was conducted to evaluate the safety and effectiveness of Xiehe smart bra for breast disease screening in outpatients with breast surgery. According to the patients' wishes and written informed consent, they were randomly assigned to the study group. A total of 2000 patients were expected to be enrolled. The training group: validation group = 1:1.

详细描述

This study is a randomized, open, multicenter clinical study. It will be conducted in Peking Union Medical College Hospital, Shanxi Provincial People's Hospital, Beijing Third Hospital, Zhalantun ZhongMeng hospital, Chongqing Medical University affiliated university town hospital, Shenzhen People's Hospital and other national hospitals. A total of 2000 subjects are expected to participate. The patients in the group wore the device for about 3 minutes, and took photos of 5 breast sites. After that, the artificial intelligence learning was carried out on the photos of the training group. For the photos of the verification group, the algorithm obtained by the training group was compared with the existing artificial intelligence algorithms of ultrasound and molybdenum target. During the follow-up, the safety of the product was evaluated. According to the basic principles of safety and performance of who international general GHTF (sg1-n020r5) medical devices.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who are going to receive breast ultrasound and molybdenum target in breast surgery clinic;
  • Female patients (18-80 years old);
  • Signed written informed consent approved by the relevant institutional review board (IRB) or independent ethics committee (IEC)

排除标准

  • The subjects were pregnant or lactating;
  • Patients with nipple discharge;
  • Known allergy to bra materials;
  • The patients who had received breast surgery or breast puncture within half a year;
  • Patients with skin diseases.

结局指标

主要结局

Sensitivity

时间窗: baseline

Using ultrasound and / or pathological results as the gold standard, the positive rates of breast diseases (benign breast diseases and malignant breast diseases) detected by smart bra are recorded.

次要结局

  • Specificity(baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验